Evidence map›Paper›PMID 40337305›Full record

ArticleRSC medicinal chemistry2025

Discovery of novel antimyeloma agents targeting TRIP13 by molecular modeling and bioassay.

Samuel Jacob Bunu, Haiyan Cai, Zhaoyin Zhou, Yanlei Zhang, Yue Lai, Guanli Wang, Dongliang Song, Chengkun Wu, Hang Zheng, Zhijian Xu and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Samuel Jacob BunuState Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai 201203 China.ORCID https://orcid.org/0000-0001-5347-9383
Haiyan CaiDepartment of Hematology, Shanghai East Hospital, Tongji University School of Medicine Shanghai 200120 China.ORCID https://orcid.org/0000-0002-0280-4331
Zhaoyin ZhouState Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai 201203 China.
Yanlei ZhangDepartment of Hematology, Shanghai East Hospital, Tongji University School of Medicine Shanghai 200120 China.
Yue LaiDepartment of Hematology, Shanghai East Hospital, Tongji University School of Medicine Shanghai 200120 China.
Guanli WangDepartment of Hematology, Shanghai East Hospital, Tongji University School of Medicine Shanghai 200120 China.
Dongliang SongDepartment of Hematology, Shanghai East Hospital, Tongji University School of Medicine Shanghai 200120 China.
Chengkun WuNational Key Laboratory of Parallel and Distributed Computing & Laboratory of Digitizing Software for Frontier Equipment, National University of Defense Technology Changsha 410073 Hunan China.
Hang ZhengDP Technology Beijing 100089 China.
Zhijian XuState Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai 201203 China.ORCID https://orcid.org/0000-0002-3063-8473
Jumei ShiDepartment of Hematology, Shanghai East Hospital, Tongji University School of Medicine Shanghai 200120 China.
Weiliang ZhuState Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai 201203 China.ORCID https://orcid.org/0000-0001-6699-5299

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroid hormone receptor-interacting protein-13 (TRIP13) is an AAA

Identifiers

PMID40337305
PMCPMC12053442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.